---
title: "Research Project on Alzheimer's Disease Among African Americans Terminated by Trump Administration"
url: https://newscentral.site/research-project-on-alzheimer-s-disease-among-african-americans/
language: en
publisher: "News Central Site"
section: "Health"
published: 2026-11-22T12:05:44.000Z
updated: 2026-11-22T15:25:58.040Z
id: 44cf744b-157e-4c9f-805d-cf97b2415368
source: "ABC News Health https://abcnews.com/Health/wireStory/scientists-fighting-halted-funds-trust-black-communities-harder-138356603"
attribution: "Link to https://newscentral.site/research-project-on-alzheimer-s-disease-among-african-americans/ and name News Central Site when you quote or summarize this story."
---

# Research Project on Alzheimer's Disease Among African Americans Terminated by Trump Administration

The study, which aimed to identify risk factors for Alzheimer's in African Americans, has been abruptly cancelled by the Trump administration.

A research project focused on uncovering the reasons behind the higher incidence of Alzheimer's disease among African Americans has been abruptly terminated by the Trump administration.

The study was conducted in a predominantly Black neighborhood in Pittsburgh, where participants underwent memory tests, sleep and blood pressure tracking, and shared their life stories to help researchers identify potential risk factors for Alzheimer's.

Researchers claim that the project's premature cancellation not only squandered over $8 million of taxpayer funds already invested but also left the study participants in limbo, without any knowledge about the results of their brain tests.

Participants like Roderick Blair, who spent four years participating in the study, are now facing uncertainty and frustration. They came into our community, took everything from us, and then left us hanging, Blair said, expressing his concerns about the abrupt termination of the project.

The distrust of U.S. health institutions within the Black community is a long-standing issue, rooted in historical racial disparities in healthcare, unequal access to medical care, and systemic biases within the nation's medical system.

The Pittsburgh-based research study had made significant strides in bridging the trust gap between healthcare providers and the Black community by engaging local residents and encouraging open discussions about memory loss and dementia.

This grassroots approach helped to dispel misconceptions and myths surrounding these conditions, with participants increasingly seeking information on how to identify and address them. In fact, Wagner reported that families who had previously dismissed memory loss as a sign of depression were now asking about dementia, while community members outside the study were inquiring about including their relatives.

It's not surprising that many Black Americans hold misconceptions about memory loss, with over half believing it is a natural part of aging rather than a disease. This widespread misconception highlights the urgent need for targeted education and awareness campaigns to dispel these myths.

Researchers pointed out that the project was unfairly stripped of funding by the National Institutes of Health, which deemed it "not science despite rigorous review and community input. According to Wagner, this decision was particularly galling given the study's focus on real-world issues affecting the Black community.

The termination of research grants by the National Institutes of Health (NIH) has left many scientists scrambling to salvage their projects. For Negar Fani, a neuropsychologist at Emory University in Atlanta, the loss was particularly devastating as she had invested two years into a five-year study on how racial discrimination affects the brain and body of Black Americans.

The NIH's decision to terminate Fani's $2.9 million grant has left her team struggling to explain their situation to participants who feel abandoned. The study had already enrolled 66 out of its planned 220 participants, but the NIH deemed it not scientific" and "subjective. This criticism is puzzling given that the research was initially approved and had a clear focus on real-world issues affecting Black communities.

Fani's experience is not an isolated incident, as numerous researchers are finding themselves at odds with the NIH over grant funding. In one notable case, study lead researcher Andrea Rosso has joined a lawsuit against the NIH and its parent Department of Health and Human Services. The lawsuit is part of a growing body of legal actions taken by scientists who feel their work is being unfairly targeted.

The criteria used to halt grants are often vague, but include descriptions that mention disparities", "minority" and "racial. These terms have become red flags for the administration, which has been actively hunting down and halting medical grants. As a result, researchers like Fani are left to pick up the pieces and try to find alternative funding to complete their studies.

The lawsuit against HHS has gained more plaintiffs, including Ann Cohen, a prominent figure in Alzheimer's disease research. Her own study was halted after three years, despite having spent $5.2 million on it. The abrupt termination of her project raises an unsettling question: what to do with the blood samples collected from participants.

Cohen's words echo through the debate: You lose trust a hell of a lot faster than you build it. Her concern is not unique, as many in the research community share similar fears about the erosion of public trust. The abrupt changes in funding priorities have created uncertainty and anxiety among researchers.

The shift in priorities at NIH has been drastic, with 2,000 fewer grants awarded this year compared to last year's total. This means a $200 million reduction in funding for multiyear studies. The Association of American Medical Colleges report highlights the significant drop in research investments. The implications are far-reaching and concerning, especially considering the emphasis on rigorous research that will supposedly improve health outcomes.

Jill Rosenthal, director of public health policy at the Center for American Progress, is vocal about her discontent with the new approach: Many decisions are based on political biases rather than evidence-based processes. Her critique underscores the perceived disconnect between research priorities and actual needs.

The abrupt halt in funding for certain research projects has left scientists frustrated and concerned about the impact on public health. Resources are being squandered as valuable opportunities to find cures for diseases are being missed.

Community trust is also at stake, particularly in Pittsburgh where researchers had built a decade-long relationship with study participants. The study's findings on Alzheimer's risk factors are now gathering dust, and the broken promises have eroded the trust that was carefully cultivated over years. Rebuilding this trust will be a long-term effort, as Blair, a study participant, acknowledged: It's going to take years to reestablish something that was moving pretty good."

---
Source: [ABC News Health](https://abcnews.com/Health/wireStory/scientists-fighting-halted-funds-trust-black-communities-harder-138356603)  
Published by News Central Site: https://newscentral.site/research-project-on-alzheimer-s-disease-among-african-americans/
